21 related articles for article (PubMed ID: 9782074)
1. Traditional processing increases biological activities of Dendrobium offificinale Kimura et. Migo in Southeast Yunnan, China.
Zhou D; Zhao Y; Chen Z; Yan X; Zhao Y; Gao L; Yang L
Sci Rep; 2022 Aug; 12(1):14814. PubMed ID: 36045147
[TBL] [Abstract][Full Text] [Related]
2. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
Jagetia GC; Reddy TK; Malagi KJ; Nayak BS; Naidu MB; Ravikiran PB; Kamath SU; Shetty PC; Reddy DS
Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569
[TBL] [Abstract][Full Text] [Related]
3. The antitumor effects of tetrodotoxin and/or doxorubicin on Ehrlich ascites carcinoma-bearing female mice.
El-Dayem SM; Fouda FM; Ali EH; Motelp BA
Toxicol Ind Health; 2013 Jun; 29(5):404-17. PubMed ID: 22317827
[TBL] [Abstract][Full Text] [Related]
4. Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity.
al-Shabanah OA; Badary OA; Nagi MN; al-Gharably NM; al-Rikabi AC; al-Bekairi AM
J Exp Clin Cancer Res; 1998 Jun; 17(2):193-8. PubMed ID: 9700580
[TBL] [Abstract][Full Text] [Related]
5. Effect of Cremophor EL on the pharmacokinetics, antitumor activity and toxicity of doxorubicin in mice.
Badary OA; Al-Shabanah OA; Al-Gharably NM; Elmazar MM
Anticancer Drugs; 1998 Oct; 9(9):809-15. PubMed ID: 9840728
[TBL] [Abstract][Full Text] [Related]
6. Modulatory effects of melatonin and vitamin E on doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma-bearing mice.
Wahab MH; Akoul ES; Abdel-Aziz AA
Tumori; 2000; 86(2):157-62. PubMed ID: 10855855
[TBL] [Abstract][Full Text] [Related]
7. L-histidinol in experimental cancer chemotherapy: improving the selectivity and efficacy of anticancer drugs, eliminating metastatic disease and reversing the multidrug-resistant phenotype.
Warrington RC
Biochem Cell Biol; 1992 May; 70(5):365-75. PubMed ID: 1353969
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of anticancer agent activity by selective inhibition of rapidly proliferating tissues of the host.
Stolfi RL; Martin DS
Pharmacol Ther; 1991; 49(1-2):43-54. PubMed ID: 1712975
[TBL] [Abstract][Full Text] [Related]
9. Effects of L-histidinol on the antitumour activity and acute cardiotoxicity of doxorubicin in mice.
Al-Shabanah OA; Badary OA; Al-Gharably NM; Al-Sawaf HA
Pharmacol Res; 1998 Sep; 38(3):225-30. PubMed ID: 9782074
[TBL] [Abstract][Full Text] [Related]
10. A novel approach for improving the efficacy of experimental cancer chemotherapy using combinations of anticancer drugs and L-histidinol.
Warrington RC
Anticancer Res; 1986; 6(3 Pt B):451-64. PubMed ID: 3090929
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]